October 21st, 2009 -- Posted in Prostacet |
Thompson is professor and chairman of the responsibility of Urology and holds the Glenda and Gary Woods Distinguished Chair in Genitourinary Oncology at the Cancer Therapy & Research Center at the UT Health Science Center at San Antonio and the Henry B. and the Edna Smith Dielmann Memorial Chair in Urologic Science at the UT Health Science Center. He led the Prostate Cancer Prevention Trial, a exploration of 18,882 men from around the U.S. that demonstrated that the Treatment Finasteride reduces a man’s endanger of Prostate Cancer by 24.8 percent.
In distinction with bust and Prostate Cancer, Screening for cervical and colon Cancer - and the wasting of freakish combination - has led to a significant drop in in invasive Cancer. Screening is “most prominent when pre-malignant lesions can be detected and eliminated” such as during colonoscopies, said the authors. The authors suggest that to put Screening, “a imaginative hub is Recommended for fact-Finding and safe keeping to ally markers that draw a distinction minimal-risk from high-risk Sickness (and) categorize less quarrelsome interventions for minimal-risk Cancer to subdue Therapy gravamen for Patients and society.” The authors catalogue four recommendations in their call to Action for initially Detection and prevention: Develop Tests to separate between Cancers that are lethal and those that are low-risk. Reduce remedying for low-risk Disease.
continue reading »
Tags:
cancer,
center,
medical,
oncology,
patient,
science,
screening
Related posts
September 19th, 2009 -- Posted in Prostacet |
Grace Lu-Yao, PhD, MPH, Cancer epidemiologist at CINJ and confidant professor of drug at UMDNJ-Robert Wood Johnson Medical School and of epidemiology at UMDNJ-School of Public Health, is the outrun founder of the JAMA Learn and the chief framer of the JNCI Study. She notes that the Survival prospect for Prostate Cancer, especially complaint detected through the PSA test, has not been well described and that the on by her crew represents the most thorough look at this subject to date. “The inadequacy of solid data has often made it intricate for Medical professionals to determine the most suited Treatment and to predict Patient outcomes for this population.
These news findings depict a more precise Survival Outcome for the contemporary Prostate Patient,” she noted. One solitary feature of the JAMA Research, according to Dr. Lu-Yao, is that more than half of the mull over subjects were over long time 78. While older men (age 75 and older) are the best years candidates for temperate Management, data definite to this age Group is sparse because this Group has often been excluded or under-represented in other Studies, according to the authors. Lu-Yao cautions that because the men in the bone up were older than 65, the observations may not fasten to younger Patients.
continue reading »
Tags:
cancer,
medical,
Prostate,
school,
umdnj
Related posts
July 2nd, 2009 -- Posted in Prostate |
Duke Prostate Center and Division of Urologic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA. We estimate the reliability of ordinary sextant Prostate Biopsy to catch unilateral lesions. A unalloyed of 365 men with over records including all Clinical and pathologic variables who underwent a preoperative sextant Biopsy and later militant Prostatectomy (RP) for clinically localized Prostate Cancer at our Medical Center between January 1996 and December 2006 were identified. When the sextant Biopsy detects unilateral Disease, according to RP Results, the NPV is great in extent (91%) with a debilitated faked dissentious gauge (9%).
However, the sextant Biopsy has a PPV of 28% with a steep fabricated Beneficial scold (72%). Therefore, a designated sextant Prostate Biopsy cannot contribute reliable, for detail Information about the unilaterality of Tumor lesion(s). Written by: Mayes JM, Mouraviev V, Sun L, Tsivian M, Madden JF, Polascik TJ. Reference: Urol Oncol. 2009 May 16. Epub before of print.
continue reading »
Tags:
biopsy,
center,
medical,
Prostate,
sextant,
unilateral
Related posts
May 9th, 2009 -- Posted in Prostate |
The 2009 State Medical Facilities Plan tenacious there was a deprivation within North Carolina for a Center to analyse Prostate Cancer, extraordinarily in African-American men. While the envisage normally establishes needs by county, the Prostate Center would favourable as a statewide facility. Carol Potter, a Country Medical facilities planner, says the strange ease will serve as a defacto test locality to determine if more single-specialty facilities should be constructed throughout the state.
The four healthiness care providers have submitted applications to the Division of Health Service Regulation for certificates of for to obtain the project. The certificate of necessity System plant to contain Health care costs by limiting peerless expenditures. UNC Hospitals has proposed Erection a $4.7 million Center on the Hospital’s mains campus in Chapel Hill. , which has been doing firm as Cary Urology, has submitted plans for a $9.9 million readiness on Waverly Drive in Raleigh.
continue reading »
Tags:
campus,
carolinas,
center,
facilities,
medical,
million,
Prostate
Related posts
April 24th, 2009 -- Posted in Prostate |
Newswise - Researchers at The Mount Sinai Medical Center in New York have found that, when it comes to worrying about the Recurrence of Prostate Cancer, c spear Patients badger less than their Female Spouses or partners. The look at was presented today at the 30th Annual joining of the Society of Behavioral Medicine in Montreal. In a swotting of 96 men and their Spouses or partners, Michael Diefenbach, Ph.D., Associate Professor of Urology and Oncological Sciences at Mount Sinai School of Medicine, found that, at the era of Prostate Cancer Diagnosis, the manful Patients described themselves as “moderately worried” about the jeopardize of their disability Recurring, while their Female Spouses and partners described themselves as “very much” worried.
“We Positive that complaint idea and worries about Cancer Recurrence change the hotheaded well-being of Patients. But our Studies show that this tease is indeed a greater accentuate on Spouses and partners. This inquire into can mitigate us begin programs to Location the fervid condition of the entire Family unit,” said Dr. Diefenbach.
continue reading »
Tags:
cancer,
medical,
mount,
partners,
patients,
sinai,
spouses
Related posts
March 30th, 2009 -- Posted in Prostacet |
For men with disconsolate Testosterone, compelling Supplements can unaccommodating greater libido, energy and muscle. It also goes against decades of Medical thinking. Judy Foreman, Health Sense March 30, 2009 Manny Hamelburg, 68, a retired businessman, had fought Prostate Cancer for years.
First, he Tried Radiation, then a upper with string crap that nearly killed him, and for ever Lupron, a Treatment that blocks shaping of Testosterone, the Hormone that can nourish Prostate Cancer. The Cancer disappeared. But effervescence was miserable. Without stable Levels of Testosterone, Hamelburg says, he had no energy, and “zero libido for Seven years. I was peer a eunuch. I was chemically castrated. Sex was just hugs.
continue reading »
Tags:
cancer,
doctors,
medical,
morgentaler,
Prostate,
testosterone
Related posts
January 17th, 2009 -- Posted in Prostate |
Physician-scientists are tiring to uncover behalf of the Disease’s molecular fingerprint, with the Count of explaining why some forms metastasize. Their findings may inform physicians afford tailored, and therefore, more effective Treatments for Patients. Dr. Mark A. Rubin, professor of Pathology and laboratory Medicine, and corruption moderator for speculative Pathology at Weill Cornell Medical College, and attending pathologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, believes that the communal joining of two genes to course a late fusion gene influences a decided kind of Prostate Cancer that is more Aggressive and responsive to hormones.
In a recent article published in the Journal of the National Cancer Institute, Dr. Rubin describes how in wing to the c spear Hormone Testosterone, Estrogen - typically tinge of as a Female Hormone - can nourish this fusion gene. Dr. Rubin’s bundle is currently exploring how this machine may help us understand how pugnacious Prostate Cancer progresses in the absence of manly hormones. Currently, Dr. Rubin and his and mate Dr. Francesca Demichelis, assistant professor in Pathology and laboratory Medication and computational biomedicine at the Institute of Computational Biomedicine at Weill Cornell Medical College, are Testing Blood samples and comparing the DNA of over 2,500 men with and without Prostate Cancer.
continue reading »
Tags:
cancer,
medical,
Prostate,
rubin
Related posts
